Balyasny Asset Management LLC Neurocrine Biosciences Inc Call Options Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$89.53 - $104.87 $4.48 Million - $5.24 Million
50,000 New
50,000 $4.72 Million
Q4 2019

Feb 14, 2020
SELL
$86.8 - $118.57 $20.8 Million - $28.5 Million
-240,000 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$83.82 - $101.5 $10.9 Million - $13.2 Million
129,600 Added 117.39%
240,000 $21.6 Million
Q2 2018

Aug 14, 2018
BUY
$75.3 - $105.99 $8.31 Million - $11.7 Million
110,400 New
110,400 $10.8 Million

Others Institutions Holding NBIX

# of Institutions
625
Shares Held
94.2M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email